ST. LOUIS, June 15 /PRNewswire/ -- The National Eye Institute, of the U.S. National Institutes of Health, announced the launch of an ancillary study to the ongoing Age-Related Eye Disease Study 2 (AREDS2). AREDS2 is a nationwide study of 4,000 individuals at moderate to high risk for developing age-related macular degeneration (AMD) to determine whether oral supplementation of lutein/zeaxanthin and omega-3 fatty acids can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.
The objective of this ancillary study is to determine if home monitoring using the ForeseeHome™ AMD Monitor would lead to earlier detection of wet AMD when compared with standard care, and result in better visual acuity following therapy at one year.
The ForeseeHome™ AMD Monitor is the first ophthalmic device designed to provide ongoing monitoring of patients with AMD between visits to their eye care professional. Patients complete a brief exam on their ForeseeHome™ AMD Monitor in the comfort of their own home, and data are transmitted to the Notal Vision Data Monitoring Center. The award winning ergonomic design of the ForeseeHome™ AMD Monitor is comfortable and easy to use for patients at risk of vision loss from AMD.
Notal Vision was founded by a team of medical professionals determined to develop better methods of AMD monitoring and reduce vision loss associated with AMD. For more information, please visit www.notalvision.com.
The National Eye Institute (NEI) is part of the National Institutes of Health (NIH) and is the Federal government's lead agency for vision research that leads to sight-saving treatments and plays a key role in reducing visual impairment and blindness. For more information, visit the NEI Website at http://www.nei.nih.gov/.
The National Institutes of Health (NIH) - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.
|SOURCE Notal Vision|
Copyright©2010 PR Newswire.
All rights reserved